Budd D C, Nicholls D G
Department of Biochemistry, University of Dundee, Scotland.
J Neurochem. 1995 Aug;65(2):615-21. doi: 10.1046/j.1471-4159.1995.65020615.x.
KCl-evoked glutamate exocytosis from cerebrocortical synaptosomes can be inhibited by the adenosine A1 receptor agonist cyclohexyladenosine (CHA). Inhibition is associated with a decreased KCl-evoked Ca2+ level elevation, and the effect of the agonist is occluded by prior incubation with the Agelenopsis aperta neurotoxin omega-agatoxin-IVA at 250 nM. The inhibition is suppressed in the presence of 3 nM phorbol dibutyrate (PDBu) or by activation of the protein kinase C (PKC)-coupled metabotropic glutamate receptor by 100 microM (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate [(1S,3R)ACPD]. A tonic inhibition of release by leaked exogenous adenosine can be reversed by adenosine deaminase or by PDBu addition. The CHA-induced inhibition can be enhanced by the PKC inhibitor Ro 31-8220. The mechanism for the suppression of the adenosine A1 receptor-mediated inhibition is distinct from that previously described for the (1S,3R)ACPD-evoked, PKC-mediated, facilitatory pathway, which enhances phosphorylation of the MARCKS protein, 4-aminopyridine-induced action potentials, and release of glutamate because the latter requires at least 100 nM PDBu [or the combination of (1S,3R)ACPD and arachidonic acid] and is not seen following KCl depolarization. Both PKC-mediated pathways may be involved in the presynaptic events associated with the establishment of synaptic plasticity.
腺苷A1受体激动剂环己基腺苷(CHA)可抑制氯化钾诱发的大脑皮质突触体谷氨酸释放。这种抑制作用与氯化钾诱发的钙离子水平升高的降低有关,并且在250 nM浓度下预先用黑寡妇蜘蛛神经毒素ω-芋螺毒素-IVA孵育后,激动剂的作用会被阻断。在存在3 nM佛波酯(PDBu)或通过100 μM(1S,3R)-1-氨基环戊烷-1,3-二羧酸[(1S,3R)ACPD]激活蛋白激酶C(PKC)偶联的代谢型谷氨酸受体时,这种抑制作用会被抑制。外源性腺苷泄漏对释放的持续性抑制可通过腺苷脱氨酶或添加PDBu来逆转。PKC抑制剂Ro 31-8220可增强CHA诱导的抑制作用。腺苷A1受体介导的抑制作用的抑制机制与先前描述的(1S,3R)ACPD诱发的、PKC介导的促进性途径不同,后者可增强MARCKS蛋白的磷酸化、4-氨基吡啶诱发的动作电位以及谷氨酸的释放,因为后者至少需要100 nM PDBu[或(1S,3R)ACPD与花生四烯酸的组合],并且在氯化钾去极化后不会出现。两种PKC介导的途径可能都参与了与突触可塑性建立相关的突触前事件。